Johnson & Johnson (BUE:JNJ) Forward PE Ratio

: 5.53 (As of Today)

View and export this data going back to . Start your Free Trial

Johnson & Johnson's Forward PE Ratio for today is 5.53.

Johnson & Johnson's PE Ratio without NRI for today is 15.21.

Johnson & Johnson's PE Ratio for today is 12.11.

Johnson & Johnson Forward PE Ratio Historical Data

The historical data trend for Johnson & Johnson's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Annual Data

Trend

2015-12

2016-12

2017-12

2018-12

2019-12

2020-12

2021-12

2022-12

2023-12

2024-04

Forward PE Ratio

16.89

16.29

17.70

16.53

19.76

29.33

32.57

10.98

5.87

5.61

Johnson & Johnson Quarterly Data
	2015-12	2016-03	2016-06	2016-09	2016-12	2017-03	2017-06	2017-09	2017-12	2018-03	2018-06	2018-09	2018-12	2019-03	2019-06	2019-09	2019-12	2020-03	2020-06	2020-09	2020-12	2021-03	2021-06	2021-09	2021-12	2022-03	2022-06	2022-09	2022-12	2023-03	2023-06	2023-09	2023-12	2024-03
Forward PE Ratio	16.89	16.39	17.21	16.58	16.29	17.64	19.01	17.06	17.70	15.65	12.95	16.10	16.53	13.68	16.08	15.41	19.76	19.05	27.10	31.35	29.33	27.55	30.96	30.67	32.57	30.40	34.01	32.79	10.98	9.54	10.35	11.14	5.87	6.25

Competitive Comparison

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Johnson & Johnson Forward PE Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Forward PE Ratio falls into.

Johnson & Johnson Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Johnson & Johnson (BUE:JNJ) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Johnson & Johnson Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Johnson & Johnson (BUE:JNJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (BUE:JNJ) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

JNJ:USA JNJ:Peru JNJ:Mexico JNJ_KZ:Kazakhstan 1JNJ:Italy JNJd:UK 0R34:UK JNJ:Germany JNJ:Canada JNJB34:Brazil JNJ:Austria

Address

One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933

Website

https://www.jnj.com

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.